These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8462563)

  • 21. Fitness of macrolide resistant Campylobacter coli and Campylobacter jejuni.
    Zeitouni S; Collin O; Andraud M; Ermel G; Kempf I
    Microb Drug Resist; 2012 Apr; 18(2):101-8. PubMed ID: 22324770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method].
    Žemličková H; Jakubů V; Marejková M; Urbášková P
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates.
    Ruiz J; Goñi P; Marco F; Gallardo F; Mirelis B; Jimenez De Anta T; Vila J
    Microbiol Immunol; 1998; 42(3):223-6. PubMed ID: 9580533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythromycin and ciprofloxacin resistant Campylobacter jejuni].
    Afset JE; Maeland JA
    Tidsskr Nor Laegeforen; 2001 Aug; 121(18):2152-4. PubMed ID: 11571989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H; Bébéar C
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrolide resistance in Campylobacter jejuni and Campylobacter coli.
    Gibreel A; Taylor DE
    J Antimicrob Chemother; 2006 Aug; 58(2):243-55. PubMed ID: 16735431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.
    Smith KE; Besser JM; Hedberg CW; Leano FT; Bender JB; Wicklund JH; Johnson BP; Moore KA; Osterholm MT
    N Engl J Med; 1999 May; 340(20):1525-32. PubMed ID: 10332013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to bile salts and sodium deoxycholate in macrolide- and fluoroquinolone-susceptible and resistant Campylobacter jejuni and Campylobacter coli strains.
    Mavri A; Smole Možina S
    Microb Drug Resist; 2013 Jun; 19(3):168-74. PubMed ID: 23289436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.
    Kuo CC; Jackson LA; Lee A; Grayston JT
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2669-70. PubMed ID: 8913488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo.
    Bakeli G; Sato K; Kumita W; Saito R; Ono E; Chida T; Okamura N
    J Infect Chemother; 2008 Oct; 14(5):342-8. PubMed ID: 18936886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.
    Rautelin H; Renkonen OV; Kosunen TU
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2065-9. PubMed ID: 1759828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A seventeen-year observation of the antimicrobial susceptibility of clinical Campylobacter jejuni and the molecular mechanisms of erythromycin-resistant isolates in Beijing, China.
    Zhou J; Zhang M; Yang W; Fang Y; Wang G; Hou F
    Int J Infect Dis; 2016 Jan; 42():28-33. PubMed ID: 26594011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential development of resistance to fluoroquinolones and erythromycin in an isolate of Campylobacter jejuni.
    Burnens AP; Heitz M; Brodard I; Nicolet J
    Zentralbl Bakteriol; 1996 Mar; 283(3):314-21. PubMed ID: 8861869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997.
    Thwaites RT; Frost JA
    J Clin Pathol; 1999 Nov; 52(11):812-4. PubMed ID: 10690169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin.
    Taylor DE; Chang N
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1917-8. PubMed ID: 1659309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azithromycin resistance in Campylobacter jejuni and Campylobacter coli.
    Rautelin H; Renkonen OV; Kosunen TU
    Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):864-5. PubMed ID: 8112360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
    Gibreel A; Wetsch NM; Taylor DE
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3212-6. PubMed ID: 17606685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms.
    Bolinger H; Kathariou S
    Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411226
    [No Abstract]   [Full Text] [Related]  

  • 39. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences.
    Engberg J; Neimann J; Nielsen EM; Aerestrup FM; Fussing V
    Emerg Infect Dis; 2004 Jun; 10(6):1056-63. PubMed ID: 15207057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].
    García-Campos JA; Alarcón T; Domingo D; Menéndez-Rivas M; López-Brea M
    Rev Esp Quimioter; 2003 Jun; 16(2):216-20. PubMed ID: 12973460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.